SINTX Announces Milestones In The Development and Testing of Antipathogenic FabricsGlobeNewsWire • 02/23/22
SINTX Chief Scientific Officer Retires and Director of R&D Steps Into Leadership RoleGlobeNewsWire • 12/31/21
SINTX Technologies Ships New FleX SN Porous and Laser-textured Spinal ImplantsGlobeNewsWire • 10/06/21
National Institute of Health Awards SINTX Technologies Phase 1 Grant for SN-PEEK 3D Printed Spinal ImplantsGlobeNewsWire • 09/22/21
SINTX Technologies Announces Adjournment of Annual Meeting of Stockholders Due to Lack of QuorumGlobeNewsWire • 09/15/21
SINTX Enters Ceramic Armor Market Through Purchase of Assets from B4C, LLC and Technology License from Precision Ceramics USA Inc.Business Wire • 07/22/21
SINTX Technologies Announces the Sale of First Silicon Nitride Antipathogenic Powder to O2TODAYGlobeNewsWire • 06/30/21
Oxford Performance Materials and SINTX Technologies Collaborate to Develop High Performance Coating SolutionGlobeNewsWire • 06/16/21
SINTX Technologies Announces New Product Brand, FleX SN, For Antipathogenic and Biomedical ApplicationsGlobeNewsWire • 05/11/21
SINTX Technologies Files Multiple New U.S. and International Patent ApplicationsGlobeNewsWire • 05/04/21